3-[[(4-Methyl-1-piperazin-yl)imino]methyl]rifamycin-D4; Abrifam-D4; Ba 41166/E-D4; Eremfat-D4; Famcin-D4; L 5103 Lepetit-D4; NSC 113926-D4; Refampicin-D4; Rifa-D4; Rifacap-D4; Rifadin-D4; Rifadine-D4; Rifaldazine-D4; Rifaldin-D4; Rifampicin SV-D4; Rifampin-D4; Rifamycin AMP-D4; Rifaprodin-D4; Rifoldin-D4; Rifoldine-D4; Riforal-D4; Rimactan-D4; Rimactane-D4; Rimapen-D4; Sinerdol-D4; Tubocin-D4;
Rifampicin-d4 is a fully characterized chemical compound used as a reference standard of API Rifampicin. The standard offered is compliant with regulatory guidelines. Rifampicin-d4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 13292-46-1 (non-labelled)
